https://www.selleckchem.com/products/nx-1607.html
An alliance of established experts on critical care, Front Line COVID-19 Critical Care Alliance (FLCCC), has published two protocols for treatment of COVID-19. The first one, methylprednisolone, ascorbic acid, thiamine, and heparin (MATH+), is intended for hospital and intensive care unit treatment of pulmonary phases of the disease. It is based on affordable, commonly available components anti-inflammatory corticosteroids (methylprednisolone, "M", high-dose vitamin C infusion (ascorbic acid, "A", vitamin B1 (thiamine, "T", anticoagu
Like
Comment
Share
